Cascadian Therapeutics completes follow-on

Cascadian Therapeutics Inc. (NASDAQ:CASC), Seattle, Wash. Business: Cancer Date completed: 2016-06-23 Type: Follow-on Raised: $28 million Shares: 35 million Price: $0.80 Shares after offering: 130 mil...